Breast Cancer Identified Risks, Diagnostic, And Treatment Advancements Worth Knowing About

Less Aggressive Chemo

Livestrong
Advertisement Loading
▾ Continue Below ▾

Super aggressive chemotherapy, when combined with a drug called trastuzumab, can work effectively in curing one early stage, yet highly aggressive, form of breast cancer, called lymph node negative HER2+ breast cancer. This type of breast cancer affects approximately fifteen to twenty percent of all breast cancer patients. Researchers are now finding a less aggressive chemotherapy drug called taxol, when combined with trastuzumab, is just as effective in helping ward off breast cancer recurrences and even death following a three-year duration. The major difference is the impact on the patient, since they seem to struggle less with the less aggressive form of chemotherapy.

Continue reading to learn about strengthening bones.

BACK
(3 of 11)
NEXT
Advertisement Loading
▾ Continue Below ▾
BACK
(3 of 11)
NEXT
Rick T
BACK
(3 of 11)
NEXT
Advertisement Loading
▾ Continue Below ▾
Advertisement Loading
▾ Continue Below ▾

MORE FROM HEALTHPREP

    Advertisement Loading
    ▾ Continue Below ▾
    Advertisement Loading
    ▾ Continue Below ▾
    Advertisement Loading
    ▾ Continue Below ▾
    Advertisement Loading
    ▾ Continue Below ▾